Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastases to the Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03132922
What this trial is testing

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Who this might be right for
Urinary Bladder CancerMelanomaHead and Neck Cancer+7 more
USWM CT, LLC 71
Not applicableStudy completedNCT01965223
What this trial is testing

Phase II Study of Stereotactic Ablative Body Radiotherapy for Metastases to the Lung (TROG 13.01 SAFRON II)

Who this might be right for
CancerMetastases to the Lung
Trans Tasman Radiation Oncology Group 90
Testing effectiveness (Phase 2)WithdrawnNCT04276597
What this trial is testing

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.

Who this might be right for
Pulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more
Excel Diagnostics and Nuclear Oncology Center
Not applicableEnded earlyNCT04889989
What this trial is testing

Microwave Ablation in Chinese Patients With Lung Tumors

Who this might be right for
Cancer of the Lung
Ethicon, Inc. 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT03965468
What this trial is testing

Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC

Who this might be right for
Non-small Cell Lung CancerStage IVOligometastasis
ETOP IBCSG Partners Foundation 96
Post-approval studies (Phase 4)Ended earlyNCT00492843
What this trial is testing

Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis

Who this might be right for
Lung Cancer
Chinese Society of Lung Cancer 20
Testing effectiveness (Phase 2)UnknownNCT01812018
What this trial is testing

Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Peng Yuan 30
Not applicableStudy completedNCT06161935
What this trial is testing

Lymph Node Metastatic Pattern Based Incorporating Tumor Location, GGO Components and Size for Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer Non Small Cell
Fudan University 7,067
Large-scale testing (Phase 3)Study completedNCT00003884
What this trial is testing

Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone

Who this might be right for
Hypercalcemia of MalignancyLung CancerMetastatic Cancer+2 more
Novartis 600
Large-scale testing (Phase 3)UnknownNCT02972333
What this trial is testing

Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M

Who this might be right for
EGFR-TKI Resistant MutationNonsmall Cell Lung CancerAZD9291+1 more
Shandong Cancer Hospital and Institute 150
Post-approval studies (Phase 4)UnknownNCT01926171
What this trial is testing

Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

Who this might be right for
Non-small-cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 80
Not applicableWithdrawnNCT00506701
What this trial is testing

Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension

Who this might be right for
Chronic Obstructive Lung Disease
Herlev Hospital
Testing effectiveness (Phase 2)Study completedNCT01085565
What this trial is testing

Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System

Who this might be right for
Bone CancerBone MetastasesPain
InSightec 50
Testing effectiveness (Phase 2)Study completedNCT04233021
What this trial is testing

Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation

Who this might be right for
Non Small Cell Lung Cancer MetastaticLeptomeningeal MetastasisBrain Metastases+1 more
Intergroupe Francophone de Cancerologie Thoracique 57
Early research (Phase 1)Active Not RecruitingNCT04449874
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerAdvanced Solid Tumors
Genentech, Inc. 498
Large-scale testing (Phase 3)Study completedNCT05614518
What this trial is testing

Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT

Who this might be right for
Bone Metastases
HTA Co., Ltd. 280
Early research (Phase 1)Study completedNCT03881488
What this trial is testing

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

Who this might be right for
Locally Advanced Solid TumorMetastatic CancerNon-small Cell Lung Cancer+4 more
Compass Therapeutics 100
Early research (Phase 1)Active Not RecruitingNCT04886804
What this trial is testing

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Who this might be right for
Neoplasm MetastasisNon-Small Cell Lung Cancer
Boehringer Ingelheim 554
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083687
What this trial is testing

Lorlatinib in ROS1+ NSCLC With Brain Metastasis

Who this might be right for
Lung Cancer (NSCLC)
Hunan Cancer Hospital 21
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Next Page